Addressing Health Equity in Genitourinary Cancer Clinical Trials
Treating mCRPC After Progression: The Potential Role of 225Ac-J591
An Exploration of Current and Emerging Therapies for mCRPC
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
How Do We Implement ANNEXXa-I Into Our Clinical Practice?
Inflammatory Breast Cancer: A New Scoring System Proposed
Filipa Lynce, MD
PeerSABCS 2023: A Look into New Research for Inflammatory Breast Cancer
Filipa Lynce, MD
PeerA Look at What’s New in Invasive Lobular Carcinoma
Antibody-Drug Conjugates: An Emerging Approach in NSCLC Treatment